BrightAccountsProduction v1.0.0 v1.0.0 2025-04-06 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is providing consultancy services to foreign medical professionals. 10 June 2026 1 8 NI616503 2026-04-05 NI616503 2025-04-05 NI616503 2024-04-05 NI616503 2025-04-06 2026-04-05 NI616503 2024-04-06 2025-04-05 NI616503 uk-bus:PrivateLimitedCompanyLtd 2025-04-06 2026-04-05 NI616503 uk-curr:PoundSterling 2025-04-06 2026-04-05 NI616503 uk-bus:SmallCompaniesRegimeForAccounts 2025-04-06 2026-04-05 NI616503 uk-bus:AbridgedAccounts 2025-04-06 2026-04-05 NI616503 uk-core:ShareCapital 2026-04-05 NI616503 uk-core:ShareCapital 2025-04-05 NI616503 uk-core:RetainedEarningsAccumulatedLosses 2026-04-05 NI616503 uk-core:RetainedEarningsAccumulatedLosses 2025-04-05 NI616503 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2026-04-05 NI616503 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-04-05 NI616503 uk-bus:FRS102 2025-04-06 2026-04-05 NI616503 uk-core:FurnitureFittingsToolsEquipment 2025-04-06 2026-04-05 NI616503 2025-04-06 2026-04-05 NI616503 uk-bus:Director1 2025-04-06 2026-04-05 NI616503 uk-bus:AuditExempt-NoAccountantsReport 2025-04-06 2026-04-05 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Company Registration Number: NI616503
 
 
Monroe Medical (NI) Ltd
 
Abridged Unaudited Financial Statements
 
for the financial year ended 5 April 2026
Monroe Medical (NI) Ltd
Company Registration Number: NI616503
ABRIDGED BALANCE SHEET
as at 5 April 2026

2026 2025
Notes £ £
 
Fixed Assets
Tangible assets 4 10,964 363
───────── ─────────
 
Current Assets
Debtors 52,904 207,997
Cash and cash equivalents 28,736 64,802
───────── ─────────
81,640 272,799
───────── ─────────
Creditors: amounts falling due within one year (94,355) (140,379)
───────── ─────────
Net Current (Liabilities)/Assets (12,715) 132,420
───────── ─────────
Total Assets less Current Liabilities (1,751) 132,783
 
Creditors:
amounts falling due after more than one year - (144,968)
───────── ─────────
Net Liabilities (1,751) (12,185)
═════════ ═════════
 
Capital and Reserves
Called up share capital 1,000 1,000
Retained earnings (2,751) (13,185)
───────── ─────────
Equity attributable to owners of the company (1,751) (12,185)
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account and Director's Report.
For the financial year ended 5 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 10 June 2026
           
           
________________________________          
Monika Milczerek          
Director          
           



Monroe Medical (NI) Ltd
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 5 April 2026

   
1. General Information
 
Monroe Medical (NI) Ltd is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI616503. The registered office of the company is 33 Sandringham Court, Carrickfergus, Co. Antrim, BT38 9BQ, Northern Ireland which is also the principal place of business of the company. The nature of the company's operations and its principal activities are set out in the Director's Report. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 5 April 2026 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Fixtures, fittings and equipment - 15% Reducing Balance
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was 1, (2025 - 8).
 
  2026 2025
  Number Number
 
Administrative 1 8
  ═════════ ═════════
       
4. Tangible assets
  Fixtures, Total
  fittings and  
  equipment  
  £ £
Cost
At 6 April 2025 1,134 1,134
Additions 11,838 11,838
  ───────── ─────────
At 5 April 2026 12,972 12,972
  ───────── ─────────
Depreciation
At 6 April 2025 771 771
Charge for the financial year 1,237 1,237
  ───────── ─────────
At 5 April 2026 2,008 2,008
  ───────── ─────────
Net book value
At 5 April 2026 10,964 10,964
  ═════════ ═════════
At 5 April 2025 363 363
  ═════════ ═════════
       
5. Capital commitments
 
The company had no material capital commitments at the financial year-ended 5 April 2026.
   
6. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.